Search Results

You are looking at 1 - 10 of 182 items for :

  • Refine by Access: All content x
Clear All
Open access

Hanbaro Kim, Ki Byung Song, Dae Wook Hwang, Jae Hoon Lee, Shadi Alshammary, and Song Cheol Kim

, poorly differentiated neuroendocrine carcinomas are recurrent and have a poor prognosis. However, there have been only a few large-sample studies investigating the pattern and prognostic factors of recurrence of PNETs. The aim of this study was to

Open access

Nidan Qiao

, 3 , 4 ). However, even under the most favorable circumstances, previous reports have found recurrence proportions of up to 10–20% after the first TS ( 5 , 6 , 7 ). Recurrent or residual CD is associated with a threefold to fivefold increase in

Open access

Alberto Giacinto Ambrogio, Massimiliano Andrioli, Martina De Martin, Francesco Cavagnini, and Francesca Pecori Giraldi

surgery but sometimes even decades after cure. Estimates of recurrence vary from 5 to 30% ( 4 , 5 , 6 ) indicating that up to one-fifth of the patients may experience a relapse of hypercortisolism. From a clinical viewpoint, this translates into the need

Open access

Jung Soo Lim, Seung-Eun Lee, Jung Hee Kim, Jae Hyeon Kim, and The Korean Adrenal Gland and Endocrine Hypertension Study Group, Korean Endocrine Society

p53 and CTNNB1 immunohistochemistry ( 18 ). Recently, progress in genomics has allowed research on the molecular prognostic markers of ACC ( 18 ). Nonetheless, there is a paucity of data on recurrence or survival in Asian patients with ACC

Open access

Pablo Abellán-Galiana, Carmen Fajardo-Montañana, Pedro Riesgo-Suárez, Marcelino Pérez-Bermejo, Celia Ríos-Pérez, and José Gómez-Vela

Introduction Transsphenoidal surgery is the treatment of choice in Cushing’s disease (CD). Following removal of the pituitary adenoma, the remission rate varies between 25 and 100% (mean 77.8%, median 78.7%), and the recurrence rate ranges

Open access

Aleksandra Kukulska, Jolanta Krajewska, Zofia Kolosza, Ewa Paliczka-Cieslik, Aleksandra Kropinska, Agnieszka Pawlaczek, Zbigniew Puch, Kornelia Ficek, Teresa Lisik, Dorota Sygula, Zbigniew Wygoda, Jozef Roskosz, Jerzy Wydmanski, and Barbara Jarzab

method to treat symptoms related to a local recurrence or MTC metastases such as pain or dyspnea, whereas adjuvant radiotherapy is usually carried out after surgery. However, its value in MTC treatment is still discussed ( 7 ). So far, there are no

Open access

C Chiapponi, H Alakus, M Faust, A M Schultheis, J Rosenbrock, and M Schmidt

prognosis. Even recurrence, which has been reported in 6.9–18% of patients within the first 5 years after initial treatment ( 6 ), can be healed by RAI re-challenge. However, in 33–55% of patients diagnosed with recurrence ( 7 ) and in approximately 5% of

Open access

Liza Das, Kim Vaiphei, Ashutosh Rai, Chirag Kamal Ahuja, Paramjeet Singh, Ishani Mohapatra, Rajesh Chhabra, Anil Bhansali, Bishan Dass Radotra, Ashley B Grossman, Márta Korbonits, and Pinaki Dutta

choice for symptomatic PPT usually by the transsphenoidal route (TSS). However, PPTs, including both pituicytomas and SCOs, often show recurrence/persistence following surgery ( 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28

Open access

Natalie Su-Jing Yap, Richard Maher, and Diana Louise Learoyd

recurrences after initial surgery (1, 2) , and this occurs predominantly in the cervical lymph nodes. Ultrasonography has high sensitivity in the detection of cervical metastases but low specificity due to frequently occurring benign lymphadenopathies (3

Open access

Huy Gia Vuong, Uyen N P Duong, Ahmed M A Altibi, Hanh T T Ngo, Thong Quang Pham, Hung Minh Tran, Greta Gandolfi, and Lewis Hassell

performed a comprehensive systematic review and meta-analysis of observational studies to examine the prognostic impact of molecular markers on tumor recurrence and cancer-related mortality in PTC. Materials and methods Literature search Four